Advertisement

Kaposi Sarcoma

  • Dorothea TerhorstEmail author
  • Martina Ulrich
  • Theodore Rosen
Chapter
  • 856 Downloads

Core Messages

  • Four main subtypes of Kaposi Sarcoma (KS) with different epidemiological profiles are recognized, all show a male predominance among affected patients. Its associated infectious agent is human herpes virus type 8.

  • Classic KS mainly affects older men of Mediterranean and Jewish lineage and generally follows an indolent clinical course with lesions that favor the skin of the lower extremities. The AIDS- associated KS almost exclusively afflicts homosexual or bisexual men and is currently considered to be a AIDS- defining disease in industrialized countries.

  • Organ transplant recipients are anouther group susceptible to develop KS.

  • African KS appears in children.

  • Important is the amelioration of immunosup-pression, besides, different local and systemic therapies are available.

Keywords

Prominent Plasma Cell Undifferentiated Spindle Cell Plasma Cell Component Focal Hemosiderin Deposition Field Electron Beam 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Schwartz RA, Micali G, Nasca MR, Scuderi L (2008) Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol 59(2):179–206PubMedCrossRefGoogle Scholar
  2. 2.
    Sullivan RJ, Pantanowitz L, Casper C, Stebbing J, Dezube BJ (2008) HIV/AIDS: epidemiology, pathophysiol-ogy, and treatment of Kaposi sarcoma-associated herpesvi-rus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis 47(9): 1209–1215PubMedCrossRefGoogle Scholar
  3. 3.
    Brenner B, Weissmann-Brenner A, Rakowsky E, Weltfriend S, Fenig E, Friedman-Birnbaum R, Sulkes A, Linn S (2002) Classical Kaposi sarcoma: prognostic factor analysis of 248 patients. Cancer 95(9):1982–1987PubMedCrossRefGoogle Scholar
  4. 4.
    Safai B, Miké V, Giraldo G, Beth E, Good RA (1980) Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications. Cancer 45(6):1472–9147PubMedCrossRefGoogle Scholar
  5. 5.
    Potthoff A, Brockmeyer NH (2007) HIV-associated Kaposi sarcoma: pathogenesis and therapy. J Dtsch Dermatol Ges 5(12):1091–1094PubMedCrossRefGoogle Scholar
  6. 6.
    Lebbé C, Legendre C, Francès C (2008) Kaposi sarcoma in transplantation. Transplant Rev (Orlando) 22(4):252–261CrossRefGoogle Scholar
  7. 7.
    Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, Schwartz RA, Seeber S (2002) Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2(5): 281–292PubMedCrossRefGoogle Scholar
  8. 8.
    Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266(5192):1865–1869PubMedCrossRefGoogle Scholar
  9. 9.
    Lebbé C (2008) [Humanes herpes virus 8 (HHV-8) and Kaposi sarcoma]. Hautarzt 59(1):18–25CrossRefGoogle Scholar
  10. 10.
    Mitsuyasu RT (1987) Clinical variants and staging of Kaposi's_sarcoma. Semin Oncol 14(2 Suppl 2):13–18PubMedGoogle Scholar
  11. 11.
    Schwartz RA, Volpe JA, Lambert MW, Lambert WC (1984) Kaposi's sarcoma. Semin Dermatol 3:303–315Google Scholar
  12. 12.
    Krown SE, Metroka C, Wernz JC (1989) Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 7(9):1201–1207PubMedGoogle Scholar
  13. 13.
    Little RF, Pluda JM, Wyvill KM et al (2006) Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma. Blood 107(12):4650–4657PubMedCrossRefGoogle Scholar
  14. 14.
    Stallone G, Infante B, Grandaliano G, Schena FP, Gesualdo L (2008) Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression. Transpl Int 21(9):825–832PubMedCrossRefGoogle Scholar
  15. 15.
    Vogt T, Brockmeyer N, Kutzner H, Schöfer H (2008) Short German guidelines: angiosarcoma and Kaposi sarcoma. J Dtsch Dermatol Ges 6(Suppl 1):S19–24PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • Dorothea Terhorst
    • 1
    Email author
  • Martina Ulrich
  • Theodore Rosen
  1. 1.Department of Dermatology, Venerology and AllergologyCharité Universty Hospital Berlin, Skin Cancer Center CharitéBerlinGermany

Personalised recommendations